GCN5L1 Aggravates Postherpetic Neuralgia Through Regulating Microglial Mitochondrial Fission-Fusion Homeostasis

Wang Li1, Xin Cao2, Shenghan Wang1

  • 1Department of Anesthesiology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.

Insights

Researchers found that GCN5L1, a mitochondrial protein, drives neuroinflammation and pain in postherpetic neuralgia (PHN) by altering microglial mitochondrial dynamics. Inhibiting GCN5L1 offers a potential therapeutic strategy for PHN management.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pain Research

Background:

  • Postherpetic neuralgia (PHN) is a chronic pain condition resulting from varicella-zoster virus (VZV) reactivation, involving persistent neuroinflammation.
  • The precise intracellular mechanisms governing microglial activation and sustained pain sensitization in PHN are not fully understood.

Purpose of the Study:

  • To investigate the role of GCN5L1, a mitochondrial acetylation modulator, in microglial activation and mitochondrial dynamics during PHN pathogenesis.
  • To explore GCN5L1 as a potential therapeutic target for alleviating PHN symptoms.

Main Methods:

  • Utilized a herpes simplex virus type 1 (HSV-1) infection mouse model to mimic PHN.
  • Assessed GCN5L1 expression and localization in the spinal dorsal horn.
  • Manipulated GCN5L1 levels in microglia (in vivo and in vitro) and evaluated neuroinflammation and pain behaviors.
  • Investigated the impact of GCN5L1 on mitochondrial dynamics (fission/fusion) and oxidative metabolism.
  • Tested the therapeutic potential of inhibiting GCN5L1 using intrathecal AAV-shGCN5L1.

Main Results:

  • GCN5L1 expression was significantly upregulated in microglia within the spinal dorsal horn following PHN induction.
  • Microglial GCN5L1 deficiency attenuated neuroinflammation and mechanical allodynia, while overexpression exacerbated these responses.
  • GCN5L1 promoted mitochondrial fission and impaired oxidative metabolism by enhancing DRP1 acetylation.
  • Restoring mitochondrial fission reversed the anti-inflammatory and analgesic effects of Gcn5l1 deficiency.
  • Intrathecal inhibition of GCN5L1 effectively suppressed neuroinflammation and mechanical allodynia in PHN mice.

Conclusions:

  • GCN5L1 is a critical regulator of microglial mitochondrial dynamics and plays a significant role in aggravating neuroinflammation and pain sensitization in PHN.
  • Targeting GCN5L1 presents a promising therapeutic avenue for managing postherpetic neuralgia.